10 “Triple A” Stocks to Buy

Advertisement

This week, 10 stocks get A’s (“strong buy”) in Portfolio Grader‘s three main grading categories, Total Grade, Overall Fundamental Grade and Quantitative Grade.

These are the best of the best in the entire Portfolio Grader database. This week, there are 4,273 stocks and only these 10 get top marks in all categories to make the elite “Triple A” stocks list. Here they are:

ABIOMED, Inc. (ABMD) provides medical devices in circulatory support and it offers a continuum of care in heart recovery to acute heart failure patients. The price of ABMD is up 92.6% since the first of the year. This is better than the Nasdaq, which has remained flat. For more information, get Portfolio Grader’s complete analysis of ABMD stock.

Chimera Investment Corporation (CIM) is a specialty finance company that invests in residential mortgage-backed securities, residential mortgage loans, real estate-related securities, and various other asset classes. The stock’s trailing PE Ratio is 5.60. For more information, get Portfolio Grader’s complete analysis of CIM stock.

Since the start of the year, CMPR has soared 15.8%. For more information, get Portfolio Grader’s complete analysis of CMPR stock.

Electronic Arts (EA) develops, publishes, and distributes branded interactive entertainment software worldwide for video game consoles, personal computers, handheld game players, and cellular handsets. Shares of the stock have risen 21.5% since January 1. For more information, get Portfolio Grader’s complete analysis of EA stock.

Edwards Group Ltd. ADR (EVAC) is an industrial technology company that manufactures and sells vacuum products and abatement systems. For more information, get Portfolio Grader’s complete analysis of EVAC stock.

1-800-FLOWERS.COM, Inc. Class A (FLWS) provides customers around the world with the freshest flowers and finest selection of plants, gift baskets, gourmet foods and confections, and plush stuffed animals perfect for every occasion. Stock prices have risen 43.2% since the first of the year. For more information, get Portfolio Grader’s complete analysis of FLWS stock.

Par Pharmaceutical (PRX) develops, manufactures and distributes generic and branded pharmaceuticals in the United States. For more information, get Portfolio Grader’s complete analysis of PRX stock.

Since the start of the year, QLYS has increased 20.4%. For more information, get Portfolio Grader’s complete analysis of QLYS stock.

Super Micro Computer, Inc. (SMCI) designs, develops, manufactures and sells application-optimized, high-performance server solutions based on a modular and open-standard architecture. For more information, get Portfolio Grader’s complete analysis of SMCI stock.

Santarus, Inc. (SNTS) is a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists and other targeted physicians. For more information, get Portfolio Grader’s complete analysis of SNTS stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/04/10-triple-a-stocks-to-buy-abmd-cim-cmpr-7/.

©2024 InvestorPlace Media, LLC